Journal of Neurochemistry · 2007 · 26 citations · 39 references
Life SciencesBiochemistryEndocrinologyCell SignalingNeuroendocrinologySignal TransductionDopaminergic SignalingHormone ReceptorsHormone Signal TransductionHormone SignalingPituitary Gland FunctionPituitary HormonesDopamine D2-like ReceptorsDopamine Receptor SubtypesDopamine-mediated InhibitionExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingPituitary Receptor SignalingReceptorsThyrotropin-releasing Hormone Regulation
Although they have distinct functions, the signaling of dopamine-D(2) receptor short and long isoforms (D(2)S and D(2)L) is virtually identical. We compared inhibitory regulation of extracellular signal-regulated kinases (ERK1/2) in GH4 pituitary cells separately transfected with these isoforms. Activation of rat or human dopamine-D(2)S, muscarinic or somatostatin receptors inhibited thyrotropin-releasing hormone-induced ERK1/2 phosphorylation, while the D(2)L receptor failed to inhibit this response. In order to address the structural basis for the differential signaling of D(2)S and D(2)L receptors, we examined the D(2)L-SS mutant, in which a protein kinase C (PKC) pseudosubstrate site that is present in the D(2)L but not D(2)S receptor was converted to a consensus PKC site. In transfected GH4 cells, the D(2)L-SS mutant inhibited thyrotropin-releasing hormone-induced ERK1/2 phosphorylation almost as strongly as the D(2)S receptor. A D(2)S-triple mutant that eliminates PKC sites involved in D(2)S receptor desensitization also inhibited ERK1/2 activation. Similarly, in striatal cultures, the D(2)-selective agonist quinpirole inhibited potassium-stimulated ERK1/2 phosphorylation, indicating the presence of this pathway in neurons. In conclusion, the D(2)S and D(2)L receptors differ in inhibitory signaling to ERK1/2 due to specific residues in the D(2)L receptor alternatively spliced domain, which may account for differences in their function in vivo.
39
Distinct functions of the two isoforms of dopamine D2 receptors
Alessandro Usiello, Ja‐Hyun Baik, Françoise Rougé‐Pont et al. · Nature · 2000 · 725 citations
Medicine, Neuroscience, Pharmacology +14